The cGAS of tumor cells has been shown to play a critical role in anti-tumor immunity, such as in the spontaneous CD8+ T cell response against mismatch repair-deficient tumor cells [51] and in the anti-tumor T cell response induced by PARP or checkpoint kinase 1 inhibitors that target the DNA damage response [52,53]. This evidence concerns the gene CD8A and neoplasm.